Search

Your search keyword '"Osawa, Takahiro"' showing total 703 results
Start Over Author "Osawa, Takahiro"
703 results on '"Osawa, Takahiro"'

1. The lymphocyte-to-monocyte ratio as a significant inflammatory marker associated with survival of patients with metastatic renal cell carcinoma treated using nivolumab plus ipilimumab therapy

Author

Numakura, Kazuyuki, Sekine, Yuya, Osawa, Takahiro, Naito, Sei, Tokairin, Ojiro, Muto, Yumina, Sobu, Ryuta, Kobayashi, Mizuki, Sasagawa, Hajime, Yamamoto, Ryohei, Nara, Taketoshi, Saito, Mitsuru, Narita, Shintaro, Akashi, Hideo, Tsuchiya, Norihiko, Shinohara, Nobuo, and Habuchi, Tomonori

Published
2024
Full Text
View/download PDF

6. Validation and motion analyses of laparoscopic radical nephrectomy with Thiel-embalmed cadavers

Author

Yan, Lingbo, Ebina, Koki, Abe, Takashige, Kon, Masafumi, Higuchi, Madoka, Hotta, Kiyohiko, Furumido, Jun, Iwahara, Naoya, Komizunai, Shunsuke, Tsujita, Teppei, Sase, Kazuya, Chen, Xiaoshuai, Kurashima, Yo, Kikuchi, Hiroshi, Miyata, Haruka, Matsumoto, Ryuji, Osawa, Takahiro, Murai, Sachiyo, Shichinohe, Toshiaki, Murakami, Soichi, Senoo, Taku, Watanabe, Masahiko, Konno, Atsushi, and Shinohara, Nobuo

Published
2024
Full Text
View/download PDF

9. Efficacy and safety of second-line cabozantinib after immuno-oncology combination therapy for advanced renal cell carcinoma: Japanese multicenter retrospective study

Author

Sazuka, Tomokazu, Matsushita, Yuto, Sato, Hiroaki, Osawa, Takahiro, Hinata, Nobuyuki, Hatakeyama, Shingo, Numakura, Kazuyuki, Ueda, Kosuke, Kimura, Takahiro, Takahashi, Masayuki, Tanaka, Hajime, Kawasaki, Yoshihide, Kurahashi, Toshifumi, Kato, Takuma, Fujita, Kazutoshi, Miyake, Makito, Kojima, Takahiro, Kitamura, Hiroshi, Miyake, Hideaki, and Ichikawa, Tomohiko

Published
2023
Full Text
View/download PDF

10. Growing Urban Tourism Activities While Increasing Vegetation Ecosystem Service Under Land Use Changes Pressure: A Case Study of Sanur, Bali, Indonesia

Author

As-syakur, Abd. Rahman, Setiawati, Martiwi Diah, Mukaromah, Laily, Osawa, Takahiro, Adnyana, I. Wayan Sandi, Sunarta, I. Nyoman, Brilly, Mitja, Advisory Editor, Davis, Richard A., Advisory Editor, Hoalst-Pullen, Nancy, Advisory Editor, Leitner, Michael, Advisory Editor, Patterson, Mark W., Advisory Editor, Veress, Márton, Advisory Editor, Chatterjee, Uday, editor, Bandyopadhyay, Nairwita, editor, Setiawati, Martiwi Diah, editor, and Sarkar, Soma, editor

Published
2023
Full Text
View/download PDF

12. Atezolizumab plus cabozantinib versus cabozantinib monotherapy for patients with renal cell carcinoma after progression with previous immune checkpoint inhibitor treatment (CONTACT-03): a multicentre, randomised, open-label, phase 3 trial

Author

Pal, Sumanta Kumar, Albiges, Laurence, Tomczak, Piotr, Suárez, Cristina, Voss, Martin H, de Velasco, Guillermo, Chahoud, Jad, Mochalova, Anastasia, Procopio, Giuseppe, Mahammedi, Hakim, Zengerling, Friedemann, Kim, Chan, Osawa, Takahiro, Angel, Martín, Gupta, Suyasha, Khan, Omara, Bergthold, Guillaume, Liu, Bo, Kalaitzidou, Melania, Huseni, Mahrukh, Scheffold, Christian, Powles, Thomas, and Choueiri, Toni K

Published
2023
Full Text
View/download PDF

14. Objective evaluation of laparoscopic surgical skills in wet lab training based on motion analysis and machine learning

Author

Ebina, Koki, Abe, Takashige, Hotta, Kiyohiko, Higuchi, Madoka, Furumido, Jun, Iwahara, Naoya, Kon, Masafumi, Miyaji, Kou, Shibuya, Sayaka, Lingbo, Yan, Komizunai, Shunsuke, Kurashima, Yo, Kikuchi, Hiroshi, Matsumoto, Ryuji, Osawa, Takahiro, Murai, Sachiyo, Tsujita, Teppei, Sase, Kazuya, Chen, Xiaoshuai, Konno, Atsushi, and Shinohara, Nobuo

Published
2022
Full Text
View/download PDF

16. MP01-03 CURRENT TREATMENT PATTERNS AND OUTCOMES OF 109 PATIENTS WITH SEX CORD STROMAL TUMORS IN JAPAN: A MULTI-INSTITUTIONAL STUDY

Author

Abe, Takashige, primary, Miyai, Kosuke, additional, Tsuzuki, Toyonori, additional, Hashine, Katsuyoshi, additional, Yamashita, Shinichi, additional, Kawahara, Takashi, additional, Nishiya, Naotaka, additional, Kitamura, Hiroshi, additional, Nishiyama, Hiroyuki, additional, Miyata, Haruka, additional, Matusmoto, Ryuji, additional, Osawa, Takahiro, additional, Murai, Sachiyo, additional, and Shinohara, Nobuo, additional

Published
2024
Full Text
View/download PDF

18. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation

Author

Kato, Taigo, Matsubara, Nobuaki, Shiota, Masaki, Eto, Masatoshi, Osawa, Takahiro, Abe, Takashige, Shinohara, Nobuo, Yasumizu, Yota, Tanaka, Nobuyuki, Oya, Mototsugu, Nishimoto, Koshiro, Hayashi, Takuji, Nakayama, Masashi, Kojima, Takahiro, Namikawa, Kenjiro, Fujisawa, Takao, Okano, Susumu, Hida, Eisuke, Nakamura, Yoshiaki, Bando, Hideaki, Yoshino, Takayuki, and Nonomura, Norio

Published
2022
Full Text
View/download PDF

19. Validation of the Japanese version of the Body Image Scale for bladder cancer patients

Author

Sato, Miho, Osawa, Takahiro, Abe, Takashige, Honda, Michitaka, Higuchi, Madoka, Yamada, Shuhei, Furumido, Jun, Kikuchi, Hiroshi, Matsumoto, Ryuji, Sato, Yasuyuki, Sasaki, Yoshihiro, Harabayashi, Toru, Maruyama, Satoru, Takada, Norikata, Minami, Keita, Tanaka, Hiroshi, Morita, Ken, Kashiwagi, Akira, Murai, Sachiyo, Ito, Yoichi M., Ogasawara, Katsuhiko, and Shinohara, Nobuo

Published
2022
Full Text
View/download PDF

20. Physiotherapy for continence and muscle function in prostatectomy: a randomised controlled trial.

Author

Ouchi, Mifuka, Kitta, Takeya, Chiba, Hiroki, Higuchi, Madoka, Abe‐Takahashi, Yui, Togo, Mio, Kusakabe, Naohisa, Murai, Sachiyo, Kikuchi, Hiroshi, Matsumoto, Ryuji, Osawa, Takahiro, Abe, Takashige, and Shinohara, Nobuo

Subjects
KEGEL exercises, MUSCLE contraction, PELVIC floor, RADICAL prostatectomy, RANDOMIZED controlled trials, RETROPUBIC prostatectomy
Abstract

Objective: To assess the effectiveness of pre‐ and postoperative supervised pelvic floor muscle training (PFMT) on the recovery of continence and pelvic floor muscle (PFM) function after robot‐assisted laparoscopic radical prostatectomy (RARP). Patients and Methods: We carried out a single‐blind randomised controlled trial involving 54 male patients scheduled to undergo RARP. The intervention group started supervised PFMT 2 months before RARP and continued for 12 months after surgery with a physiotherapist. The control group was given verbal instructions, a brochure about PFMT, and lifestyle advice. The primary outcome was 24‐h pad weight (g) at 3 months after RARP. The secondary outcomes were continence status (assessed by pad use), PFM function, and the Expanded Prostate Cancer Index Composite (EPIC) score. Results: Patients who participated in supervised PFMT showed significantly improved postoperative urinary incontinence (UI) compared with the control group (5.0 [0.0–908.0] g vs 21.0 [0.0–750.0] g; effect size: 0.34, P = 0.022) at 3 months after RARP based on 24‐h pad weight. A significant improvement was seen in the intervention compared with the control group (65.2% continence [no pad use] vs 31.6% continence, respectively) at 12 months after surgery (effect size: 0.34, P = 0.030). Peak pressure during a maximum voluntary contraction was higher in the intervention group immediately after catheter removal and at 6 months, and a longer duration of sustained contraction was found in the intervention group compared with the control group. We were unable to demonstrate a difference between groups in EPIC scores. Conclusion: Supervised PFMT can improve postoperative UI and PFM function after RARP. Further studies are needed to confirm whether intra‐anal pressure reflects PFM function and affects continence status in UI in men who have undergone RARP. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

26. Efficacy and safety of axitinib for metastatic renal cell carcinoma: Real-world data on patients with renal impairment

Author

Minami, Keita, Osawa, Takahiro, Kojima, Takahiro, Hara, Tomohiko, Eto, Masatoshi, Takeuchi, Ario, Nakai, Yasutomo, Ueda, Kosuke, Ozawa, Michinobu, Uemura, Motohide, Ohba, Kojiro, Tamura, Keita, Shindo, Tetsuya, Nakagomi, Hiroshi, Takahashi, Atsushi, Anai, Satoshi, Yokomizo, Akira, Morizane, Shuichi, Kimura, Takahiro, Shimazui, Toru, Miyauchi, Yasuyuki, Mitsuzuka, Koji, Hara, Hiroaki, Yoshimura, Koji, Shiina, Hiroaki, Ito, Youichi M, Murai, Sachiyo, Nishiyama, Hiroyuki, Shinohara, Nobuo, and Kitamura, Hiroshi

Published
2023
Full Text
View/download PDF

27. Health-related quality of life in Japanese low-risk prostate cancer patients choosing active surveillance: 3-year follow-up from PRIAS-JAPAN

Author

Hirama, Hiromi, Sugimoto, Mikio, Miyatake, Nobuyuki, Kato, Takuma, Venderbos, Lionne D. F., Remmers, Sebastiaan, Shiga, Kenichiro, Yokomizo, Akira, Mitsuzuka, Koji, Matsumoto, Ryuji, Osawa, Takahiro, Abe, Takashige, Sasaki, Hiroshi, Egawa, Shin, Ninomiya, Iku, Hashine, Katsuyoshi, Roobol, Monique J., and Kakehi, Yoshiyuki

Published
2021
Full Text
View/download PDF

29. A surgical instrument motion measurement system for skill evaluation in practical laparoscopic surgery training.

Author

Ebina, Koki, Abe, Takashige, Yan, Lingbo, Hotta, Kiyohiko, Shichinohe, Toshiaki, Higuchi, Madoka, Iwahara, Naoya, Hosaka, Yukino, Harada, Shigeru, Kikuchi, Hiroshi, Miyata, Haruka, Matsumoto, Ryuji, Osawa, Takahiro, Kurashima, Yo, Watanabe, Masahiko, Kon, Masafumi, Murai, Sachiyo, Komizunai, Shunsuke, Tsujita, Teppei, and Sase, Kazuya

Subjects
SURGICAL instruments, LAPAROSCOPIC surgery, MOTION capture (Human mechanics), SURGICAL education, OPERATIVE surgery, MEASURING instruments
Abstract

This study developed and validated a surgical instrument motion measurement system for skill evaluation during practical laparoscopic surgery training. Owing to the various advantages of laparoscopic surgery including minimal invasiveness, this technique has been widely used. However, expert surgeons have insufficient time for providing training to beginners due to the shortage of surgeons and limited working hours. Skill transfer efficiency has to be improved for which there is an urgent need to develop objective surgical skill evaluation methods. Therefore, a simple motion capture–based surgical instrument motion measurement system that could be easily installed in an operating room for skill assessment during practical surgical training was developed. The tip positions and orientations of the instruments were calculated based on the marker positions attached to the root of the instrument. Because the patterns of these markers are individual, this system can track multiple instruments simultaneously and detect exchanges. However due to the many obstacles in the operating room, the measurement data included noise and outliers. In this study, the effect of this decrease in measurement accuracy on feature calculation was determined. Accuracy verification experiments were conducted during wet-lab training to demonstrate the capability of this system to measure the motion of surgical instruments with practical accuracy. A surgical training experiment on a cadaver was conducted, and the motions of six surgical instruments were measured in 36 cases of laparoscopic radical nephrectomy. Outlier removal and smoothing methods were also developed and applied to remove the noise and outliers in the obtained data. The questionnaire survey conducted during the experiment confirmed that the measurement system did not interfere with the surgical operation. Thus, the proposed system was capable of making reliable measurements with minimal impact on surgery. The system will facilitate surgical education by enabling the evaluation of skill transfer of surgical skills. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

30. Cross‐sectional study of therapy‐related expectations/concerns of patients with metastatic renal cell carcinoma and physicians in Japan.

Author

Kimura, Go, Fujii, Yasuhisa, Osawa, Takahiro, Uchitomi, Yosuke, Honda, Kazunori, Kondo, Miki, Otani, Ariko, Wako, Tetsuya, Kawai, Daisuke, Mitsuda, Yoshihide, Sakashita, Naotaka, and Shinohara, Nobuo

Subjects
RENAL cell carcinoma, PHYSICIANS, CROSS-sectional method, JAPANESE people, PATIENTS' attitudes
Abstract

Objective: To achieve patient‐centricity in metastatic renal cell carcinoma (mRCC) treatment, it is essential to clarify the differences in perspectives between patients and physicians. This cross‐sectional analysis of a web survey aimed to clarify the differences in expectations and concerns between mRCC patients and physicians regarding systemic mRCC therapy in Japan. Methods: Surveys from 83 patients and 165 physicians were analyzed. Results: The top three most significant differences in expectations of systemic therapy between patients and physicians (patient‐based physician value) were "Chance of achieving treatment‐free status" (−30.1%, p < 0.001), "Longer survival" (+25.8%, p < 0.001), and "Chance of eliminating all evidence of disease" (−25.6%, p < 0.001). The top three most significant differences in concerns for systemic therapy between patients and physicians (patient‐based physician value) were "Lack of efficacy" (+36.1%, p < 0.001), "Lack of knowledge of treatment" (−28.2%, p < 0.001), and "Daily activities affected by side effects" (+22.3%, p < 0.001). Diarrhea, fatigue/malaise, and nausea/vomiting were patients' most distressing adverse events; 50.6% of patients had difficulty telling their physicians about adverse events such as fatigue, anxiety, and depression. Conclusions: This study demonstrated a gap between patients with mRCC and physicians in their expectations and concerns for systemic therapy. Japanese patients with mRCC suffer from a number of adverse events, some of which are not shared with physicians. This study highlights the importance of communicating well with patients in clinical practice to achieve patient‐centricity in systemic treatment for mRCC. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

31. Financial Toxicity in Japanese Patients with Metastatic Renal Cell Carcinoma: A Cross-Sectional Study.

Author

Kimura, Go, Fujii, Yasuhisa, Honda, Kazunori, Osawa, Takahiro, Uchitomi, Yosuke, Kondo, Miki, Otani, Ariko, Wako, Tetsuya, Kawai, Daisuke, Mitsuda, Yoshihide, Sakashita, Naotaka, and Shinohara, Nobuo

Subjects
CROSS-sectional method, PEARSON correlation (Statistics), RESEARCH funding, MULTIVARIATE analysis, FINANCIAL stress, METASTASIS, SURVEYS, RENAL cell carcinoma, QUALITY of life, STATISTICS
Abstract

Simple Summary: We investigated financial toxicity in Japanese patients with metastatic renal cell carcinoma using the COST tool. Despite universal coverage, patients in Japan had similar levels of financial toxicity as in other countries. There was a positive correlation between the FACT-G total score and the COST score. Age < 65 years and not having private health insurance were associated with higher financial toxicity. Information on the financial toxicity experienced by Japanese patients with metastatic renal cell carcinoma (mRCC) is lacking, even though Japan has its own unique public health insurance system. Thus, a web-based survey was conducted to evaluate the financial toxicity experienced by Japanese mRCC patients using the COmprehensive Score for financial Toxicity (COST) tool. This study enrolled Japanese patients who underwent, or were undergoing, systemic therapy for mRCC. The outcomes evaluated were the distribution of COST scores, the correlation between COST and quality of life (QOL) assessed by the Functional Assessment of Cancer Therapy-General (FACT-G) scale, and demographic factors associated with financial toxicity. The median (range) COST score was 19.0 (3.0–36.0). The Pearson correlation coefficient for COST and FACT-G total scores was 0.40. Univariate analysis revealed that not having private health insurance and lower household income per year were significantly associated with lower COST scores. Multivariate analyses showed that age < 65 years and not having private health insurance were significantly associated with lower COST scores. This study revealed that Japanese mRCC patients experience adverse financial impacts even under the universal health insurance coverage system available in Japan, and financial toxicity negatively affects their QOL. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

32. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second‐line treatment with tyrosine kinase inhibitor following first‐line immune‐oncology combination therapy.

Author

Matsushita, Yuto, Kojima, Takahiro, Osawa, Takahiro, Sazuka, Tomokazu, Hatakeyama, Shingo, Goto, Keisuke, Numakura, Kazuyuki, Yamana, Kazutoshi, Kandori, Shuya, Fujita, Kazutoshi, Ueda, Kosuke, Tanaka, Hajime, Tomida, Ryotaro, Kurahashi, Toshifumi, Bando, Yukari, Nishiyama, Naotaka, Kimura, Takahiro, Yamashita, Shimpei, Kitamura, Hiroshi, and Miyake, Hideaki

Subjects
RENAL cell carcinoma, PROTEIN-tyrosine kinase inhibitors, IPILIMUMAB, ALBUMINS, TREATMENT effectiveness, METASTASIS
Abstract

Objectives: This study aimed to assess the prognostic outcomes in mRCC patients receiving second‐line TKI following first‐line IO combination therapy. Methods: This study retrospectively included 243 mRCC patients receiving second‐line TKI after first‐line IO combination therapy: nivolumab plus ipilimumab (n = 189, IO–IO group) and either pembrolizumab plus axitinib or avelumab plus axitinib (n = 54, IO–TKI group). Oncological outcomes between the two groups were compared, and prognostication systems were developed for these patients. Results: In the IO–IO and IO–TKI groups, the objective response rates to second‐line TKI were 34.4% and 25.9% (p = 0.26), the median PFS periods were 9.7 and 7.1 months (p = 0.79), and the median OS periods after the introduction of second‐line TKI were 23.1 and 33.5 months (p = 0.93), respectively. Among the several factors examined, non‐CCRCC, high CRP, and low albumin levels were identified as independent predictors of both poor PFS and OS by multivariate analyses. It was possible to precisely classify the patients into 3 risk groups regarding both PFS and OS according to the positive numbers of the independent prognostic factors. Furthermore, the c‐indices of this study were superior to those of previous systems as follows: 0.75, 0.64, and 0.61 for PFS prediction and 0.76, 0.70, and 0.65 for OS prediction by the present, IMDC, and MSKCC systems, respectively. Conclusions: There were no significant differences in the prognostic outcomes after introducing second‐line TKI between the IO–IO and IO–TKI groups, and the histopathology, CRP and albumin levels had independent impacts on the prognosis in mRCC patients receiving second‐line TKI, irrespective of first‐line IO combination therapies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

33. Longitudinal mortality risks and kidney functional outcomes in Japanese living kidney donors.

Author

Hirose, Takayuki, Hotta, Kiyohiko, Osawa, Takahiro, Yokota, Isao, Inao, Tasuku, Tanabe, Tatsu, Iwahara, Naoya, and Shinohara, Nobuo

Subjects
KIDNEY physiology, KIDNEYS, MORTALITY, KIDNEY failure, GLOMERULAR filtration rate
Abstract

Objectives: Previous studies suggested that living kidney donors do not have a higher risk of death or kidney failure than the general population. However, living kidney donor risk is controversial. Furthermore, only a few studies have evaluated long‐term kidney function after kidney donation. Methods: This study evaluated Japanese kidney donor' long‐term outcomes, including mortality and kidney function. From 1965 to 2015, 230 donors (76 males, 154 females, and a median age of 54) were enrolled in this study. The median observation period was 11.0 (range, 0.3–41.0) years. Results: In total, 215 donors were still alive, and 15 had died. Causes of death included malignancies, cardiovascular disease, pneumonia, suicide, gastrointestinal bleeding, and kidney failure. Actual donor survival rates at 10, 20, and 30 years were 95.3%, 90.7%, and 80.9%, respectively. These values were comparable to age‐ and gender‐matched expected survival. Long‐term kidney function after donation was evaluated in 211 donors with serum creatinine data. Two donors developed kidney failure 24 and 26 years post‐donation, respectively. The percentage of donors whose estimated glomerular filtration rate (eGFR) remained ≥45 mL/min/1.73 m2 at 10, 20, and 30 years after donation were 84.2%, 73.0%, and 63.9%, respectively. Survival rates of donors with eGFR <45 mL/min/1.73 m2 were comparable to those in persons with eGFR >45 mL/min/1.73 m2. Conclusion: Our findings revealed that kidney donors did not have a higher long‐term risk of death than the general population. Although some donors showed decreased kidney function after donation, kidney function did not impact their survival. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

Author

Wong, Suet-Lai Shirley, Tan, Thean Hsiang, Hovey, Elizabeth Jane, Clay, Timothy Dudley, Wan Ng, Siobhan Su, Rutten, Annemie, Machiels, Jean-Pascal, Dumez, Herlinde, Cheng, Susanna Yee-Shan, Ferrario, Cristiano, Sengeloev, Lisa, Jensen, Niels Viggo, Thibault, Constance, Laguerre, Brigitte, Joly, Florence, Culine, Stéphane, Becht, Catherine, Niegisch, Günter, Stöckle, Michael, Grimm, Marc-Oliver, Schwentner, Christina A, Schultze-Seemann, Wolfgang, Kalofonos, Haralambos, Mavroudis, Dimitrios, Papandreou, Christos, Karavasilis, Vasilis, Révész, Janos, Rosenbaum, Eli, Leibowitz-Amit, Raya, Kejzman, Daniel, Sarid, David, Scagliotti, Giorgio Vittorio, Bracarda, Sergio, Massari, Francesco, Osawa, Takahiro, Miyajima, Naoto, Shinohara, Nobuo, Fukuta, Fumimasa, Ohyama, Chikara, Obara, Wataru, Yamashita, Shinichi, Tomita, Yoshihiko, Kawai, Koji, Fukasawa, Satoshi, Oyama, Masafumi, Yonese, Junji, Nagata, Masayoshi, Uemura, Motohide, Nishimura, Kazuo, Kawakita, Mutsushi, Tsunemori, Hiroyuki, Hashine, Katsuyoshi, Inokuchi, Junichi, Yokomizo, Akira, Nagamori, Satoshi, Lee, Hyo Jin, Park, Se Hoon, Rha, Sun Young, Kim, Yu Jung, Lee, Yun-Gyoo, Vazquez Cortés, Leticia, Lorena Urzua Flores, Claudia, Blaisse, Reinoud J.B., Erdkamp, Fransiscus L.G., Aarts, Maureen J.B., Wojcik-Tomaszewska, Joanna, Tomczak, Piotr, Sikora-Kupis, Bozena, Schenker, Michael, Herzal, Alina Amalia, Udrea, Anghel Adrian, Karlov, Petr, Fomkin, Roman, Gajate Borau, Pablo, Grande, Enrique, Delgado Mignorance, Juan Ignacio, Su, Yu-Li, Li, Jian-Ri, Lin, Chien-Liang, Lin, Chia-Chi, Yeh, Su-Peng, Erman, Mustafa, Urun, Yuksel, Golovko, Yuriy, Bondarenko, Igor, Sinielnikov, Ivan, Crabb, Simon J., Syndikus, Isabel, Huddart, Robert, Sundar, Santhanam, Chowdhury, Simon, Sarwar, Naveed, Flaig, Thomas W., Pan, Chong Xian, Schwarz, James K., Cultrera, Jennifer Lyn, Acs, Peter Istvan, Hainsworth, John D., Herms, Benjamin T., Lawler, William Eyre, Lowe, Thomas Eugene, Petrylak, Daniel P, de Wit, Ronald, Chi, Kim N, Drakaki, Alexandra, Sternberg, Cora N, Nishiyama, Hiroyuki, Castellano, Daniel, Hussain, Syed A, Fléchon, Aude, Bamias, Aristotelis, Yu, Evan Y, van der Heijden, Michiel S, Matsubara, Nobuaki, Alekseev, Boris, Necchi, Andrea, Géczi, Lajos, Ou, Yen-Chuan, Coskun, Hasan Senol, Su, Wen-Pin, Bedke, Jens, Gakis, Georgios, Percent, Ivor J, Lee, Jae-Lyun, Tucci, Marcello, Semenov, Andrey, Laestadius, Fredrik, Peer, Avivit, Tortora, Giampaolo, Safina, Sufia, Garcia del Muro, Xavier, Rodriguez-Vida, Alejo, Cicin, Irfan, Harputluoglu, Hakan, Tagawa, Scott T, Vaishampayan, Ulka, Aragon-Ching, Jeanny B, Hamid, Oday, Liepa, Astra M, Wijayawardana, Sameera, Russo, Francesca, Walgren, Richard A, Zimmermann, Annamaria H, Hozak, Rebecca R, Bell-McGuinn, Katherine M, and Powles, Thomas

Published
2020
Full Text
View/download PDF

39. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy

Author

Kikuchi, Hiroshi, primary, Abe, Takashige, additional, Miyake, Makito, additional, Miyata, Haruka, additional, Matsumoto, Ryuji, additional, Osawa, Takahiro, additional, Nishimura, Nobutaka, additional, Fujimoto, Kiyohide, additional, Inokuchi, Junichi, additional, Yoneyama, Takahiro, additional, Tomida, Ryotaro, additional, Numakura, Kazuyuki, additional, Matsushita, Yuto, additional, Matsumoto, Kazumasa, additional, Sato, Takuma, additional, Taoka, Rikiya, additional, Kobayashi, Takashi, additional, Kojima, Takahiro, additional, Matsui, Yoshiyuki, additional, Nishiyama, Naotaka, additional, Kitamura, Hiroshi, additional, Nishiyama, Hiroyuki, additional, and Shinohara, Nobuo, additional

Published
2023
Full Text
View/download PDF

40. Multi-Sensor Satellite to Assess Sea Level Rise and Land Subsidence Impact on the Flood Crisis on the East Coast of North Sumatra and Medan City, Indonesia

Author

Lumban-Gaol, Jonson, primary, Sumantyo, Josaphat Tetuko Sri, additional, Tambunan, Efendy, additional, Situmorang, David, additional, Antara, I Made Oka Guna, additional, Arhatin, Risti Endriani, additional, Osawa, Takahiro, additional, Sinurat, Maya Eria, additional, and Suhita, Ni Putu Asri Ratna, additional

Published
2023
Full Text
View/download PDF

41. Health-related quality of life in Japanese patients with bladder cancer measured by a newly developed Japanese version of the Bladder Cancer Index

Author

Osawa, Takahiro, Wei, John T., Abe, Takashige, Honda, Michitaka, Yamada, Shuhei, Furumido, Jun, Kikuchi, Hiroshi, Matsumoto, Ryuji, Hirakawa, Kazushi, Sato, Yasuyuki, Sasaki, Yoshihiro, Harabayashi, Toru, Takada, Norikata, Minami, Keita, Tanaka, Hiroshi, Morita, Ken, Kashiwagi, Akira, Miyajima, Naoto, Akino, Tomoshige, Murai, Sachiyo, Ito, Yoichi M., Fukuhara, Shunichi, Ogasawara, Katsuhiko, and Shinohara, Nobuo

Published
2020
Full Text
View/download PDF

42. A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data

Author

Hinata, Nobuyuki, Yonese, Junji, Masui, Satoru, Nakai, Yasutomo, Shirotake, Suguru, Tatsugami, Katsunori, Inamoto, Teruo, Nozawa, Masahiro, Ueda, Kosuke, Etsunaga, Toru, Osawa, Takahiro, Uemura, Motohide, Kimura, Go, Numakura, Kazuyuki, Yamana, Kazutoshi, Miyake, Hideaki, Fukasawa, Satoshi, Ochi, Kenya, Kaneko, Hirokazu, and Uemura, Hirotsugu

Published
2020
Full Text
View/download PDF

45. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy.

Author

Kikuchi, Hiroshi, Abe, Takashige, Miyake, Makito, Miyata, Haruka, Matsumoto, Ryuji, Osawa, Takahiro, Nishimura, Nobutaka, Fujimoto, Kiyohide, Inokuchi, Junichi, Yoneyama, Takahiro, Tomida, Ryotaro, Numakura, Kazuyuki, Matsushita, Yuto, Matsumoto, Kazumasa, Sato, Takuma, Taoka, Rikiya, Kobayashi, Takashi, Kojima, Takahiro, Matsui, Yoshiyuki, and Nishiyama, Naotaka

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results